Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.73 USD | -0.24% | +2.26% | +4.30% |
Jul. 02 | Innoviva, Inc.'s Subsidiary Innoviva Specialty Therapeutics, Inc. Appoints Patricia Drake as Chief Commercial Officer | CI |
Jun. 18 | Cantor Fitzgerald Initiates Innoviva at Overweight Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+4.30% | 1.04B | |
+62.66% | 854B | |
+40.42% | 636B | |
-4.37% | 361B | |
+17.16% | 324B | |
+9.87% | 301B | |
+15.66% | 247B | |
+4.21% | 230B | |
+17.90% | 228B | |
+14.86% | 177B |
- Stock Market
- Equities
- INVA Stock
- News Innoviva, Inc.
- Innoviva Agrees to Take La Jolla Pharmaceutical Private in $149 Million Acquisition Deal; Shares Rise